View Older Stories

Sep 29, 2026 06:05AM Novo Nordisk licenses oral GLP-1/GIP dual agonist from Hengrui Pharma

Sep 29, 2026 06:04AM Novo Nordisk study links semaglutide 2 mg to lower heart risk vs tirzepatide

Sep 28, 2026 10:10AM CMS pumps $51M into rural Texas to fight diabetes and obesity

Sep 25, 2026 03:25PM Viatris sues Novo Nordisk over generic Wegovy patent dispute

Sep 22, 2026 04:02PM CFRA Downgrades Novo Nordisk (NVO) to Sell

Sep 22, 2026 07:26AM Roche obesity drug shows 15.5% weight loss in diabetes trial

Sep 22, 2026 02:37AM Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK245 at Deutsche Bank

Sep 21, 2026 10:03AM Novo Nordisk shares drop as investor event disappoints

Sep 21, 2026 06:32AM Novo Nordisk CagriSema shows weight loss edge over tirzepatide in trials

Sep 21, 2026 05:30AM Novo Nordisk (NVO) call put ratio 1.8 calls to 1 put into hosting its Capital Markets Day

Sep 20, 2026 03:00PM Novo Nordisk (NVO) Capital Markets Day preview

Sep 18, 2026 06:42AM EMA panel backs Novo Nordisk's Sogroya for children's growth disorder

Sep 17, 2026 10:28AM EMA panel backs Novo Nordisk haemophilia A drug FREHEMGO

Sep 17, 2026 07:08AM Novo Nordisk publishes phase 3b data on denecimig for haemophilia A

Sep 16, 2026 08:58AM Novo Nordisk partners with Anthropic to turbocharge drug discovery

Sep 16, 2026 08:01AM Novo Nordisk and Anthropic announce R&D collaboration

Sep 15, 2026 10:51AM Novo Nordisk (NVO) call put ratio 1.7 calls to 1 put into hosting Capital Markets Day

Sep 15, 2026 06:03AM Novo Nordisk (NVO) call put ratio 1.1 calls to 1 put into Capital Markets Day

Sep 14, 2026 06:00AM Novo Nordisk rebrands to Novo with new cultural framework

Sep 11, 2026 02:20AM Morgan Stanley Downgrades Novo Nordisk (NVO) to Underweight

Sep 11, 2026 02:19AM Morgan Stanley Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Underweight

Aug 27, 2026 08:59AM Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip

Aug 27, 2026 08:27AM Novo Nordisk seeks China approval for oral Wegovy drug

Aug 25, 2026 01:54PM PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg

Aug 25, 2026 04:28AM Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK275 at JPMorgan

Aug 18, 2026 11:05AM Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"

Aug 12, 2026 03:06AM Berenberg Downgrades Novo Nordisk (NVO) to Hold

Aug 12, 2026 03:06AM Berenberg Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold

Aug 11, 2026 09:13AM Novo Nordisk launches once-weekly basal insulin Awiqli nationwide

Aug 5, 2026 10:36AM Novo Nordisk wins Dutch court order against Ceban over semaglutide

Aug 4, 2026 12:34PM Novo Nordisk raises 2026 outlook on stronger GLP-1 sales

Aug 4, 2026 11:23AM Novo Nordisk (NVO) call put ratio 2.5 call to 1 put into quarter results

Aug 4, 2026 04:40AM Novo Nordisk (NVO) call put ratio 1.9 calls to 1 put into quarter results

Aug 3, 2026 11:00AM Novo Nordisk (NVO) call put ratio 1 call to 1 put into quarter results

Jul 31, 2026 08:11AM Novo Nordisk stock tumbles 10% as key trial misses goal

Jul 31, 2026 07:26AM Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial

Jul 28, 2026 12:54PM Novo Nordisk must face fraud lawsuit over CagriSema trial, judge rules

Jul 23, 2026 10:54AM Lilly to file for next-gen obesity drug approval in early 2027

Jul 21, 2026 07:36AM Novo Nordisk sues Eli Lilly over weight-loss drug ads

Jul 15, 2026 11:53AM Novo Nordisk wins EU approval for Wegovy pill and new injection

Jun 29, 2026 06:14AM Sandoz submits generic obesity drug applications to FDA

Jun 18, 2026 05:47AM Oral Wegovy reaches 33% of total prescriptions by May

Jun 17, 2026 11:15AM Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Jun 12, 2026 02:42PM Leerink highlights drug demand rebound after Memorial Day

Jun 11, 2026 11:13AM Novo Nordisk gets UK approval for daily Wegovy weight loss pill

Jun 9, 2026 02:31PM Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows

Jun 8, 2026 03:09AM Novo Nordisk (NVO) call put ratio 2.1 calls to 1 put

Jun 5, 2026 07:38AM Morgan Stanley on Eli Lilly (LLY): 'We see ~7% upside to '26 M+Z ests'

Jun 5, 2026 07:05AM TD Cowen raises global GLP-1 sales forecast to $150B by 2030

Jun 4, 2026 08:42AM Veru partners with Novo Nordisk for obesity drug combination study

View Older Stories